Nicotinamide as a repair inhibitor in vivo: Studies using single and fractionated X-ray doses in mouse skin and kidneys

Radiation Research

Volumn 145, Issue 4, 1996, Pages 419-431

  Rojas, A ^a   Denekamp, J ^a   Johns, H ^a   Kjellen, E ^a   Tsang, R ^a   Nilsson, P ^a   Stratford, M R L ^a   Dennis, M F ^a   Joiner, M C ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EPIDERMIS; FEMALE; KIDNEY; MOUSE; NEUTRON RADIATION; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SENSITIZATION; SKIN; TISSUE REPAIR; X RAY;

ANIMALS; DNA REPAIR; FEMALE; KIDNEY; MICE; MICE, INBRED CBA; NEUTRONS; NIACINAMIDE; RADIATION INJURIES, EXPERIMENTAL; RADIATION-SENSITIZING AGENTS; SKIN; X-RAYS;

ANIMALIA; RODENTIA;

EID: 0029932043     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579063     Document Type: Article

References (49)

1. D. J. Chaplin, M. R. Horsman and D. W. Siemann, Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time. Br. J. Cancer 68. 269-273 (1993).
2. M. R. Horsman, D. J. Chaplin and J. M. Brown, Radiosensitization by nicotinamide in vivo: A greater enhancement of tumor damage compared to that of normal tissues. Radiat. Res. 109, 479-489 (1987).
3. G. G. Jonsson. E. Kjellen. R. W. Pero and R. Cameron, Radiosensitization effects of nicotinamide on malignant and normal mouse tissue. Cancer Res. 45, 3609-3614 (1985).
4. E. Kjellen. M. C. Joiner. J M. Collier. H. Johns and A. Rojas, A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments. Radiother. Oncol. 22, 81-91 (1991).
5. A. Rojas, ARCON: accelerated radiotherapy with carbogen and nicotinamide. In Radiation Science - of Molecules, Mice and Men (J. Denekamp and D. Hirst. Eds.), pp. 174-178. Suppl. 26. Br. J. Radiol., British Institute of Radiology, London, 1992.
6. E. Ben-Hur, H. Utsumi and M. M. Elkind, Inhibitors of poly(ADP-ribose) synthesis enhance radiation response by differentially affect-ing repair of potentially lethal versus sublethal damage. Br. J. Cancer 6, 39-42 (1984).
7. D. M. Brown. J. W. Evans and J. M. Brown. The influence of inhibitors of poly(ADP-ribose) polymerase on X-ray-induced potentially lethal damage repair. Br. J. Cancer 49, 27-31 (1984).
8. P. Thraves, K. L. Mossman, T. Brennan and A. Dritschilo, Radiosensitization of human fibroblasts by 3-aminobenzamide: an inhibitor of poly(ADP-ribosylation). Radiat Res. 104. 119-127 (1985).
9. K. Ikai, K. Ueda and O. Hayaishi, Immunohistochemical demonstration of poly(adenosine diphosphate-ribose) in nuclei of various rat tissues. J. Histochem. Cytochem. 28, 670-676 (1980).
10. R. C. Benjamin and D. M. Gill. Poly(ADP-ribose) synthesis in vitro programmed by damaged DNA. A comparison of DNA molecules containing different types of strand breaks. J. Biol. Chem. 255, 10502-10508 (1980).
11. R. C. Benjamin and D. M. Gill, ADP-ribosylation in mammalian cell ghosts. Dependence of poly(ADP-ribose) synthesis on strand breakage in DNA. J. Biol. Chem. 255, 10493-10501 (1980).
12. S. Shall. ADP-ribose in DNA repair: a new component of DNA excision repair. In Advances in Radiation Biology. Vol. 11 (J. T. Lett, Ed.), pp. 1-69. Academic Press, New York, 1984.
13. W. J. Whish, M. I. Davies and S. Shall, Stimulation of poly(ADP-ribose) polymerase activity by the anti-tumour antibiotic, streplozotocin. Biochem. Biophys. Res. Commun. 65. 722-730 (1975).
14. C. J. Skidmore. M. I. Davies. P. M. Goodwin. H. Halldorsson, P. J. Lewis. S. Shall and A. A. Zia'ee, The involvement of poly(ADP-ribose) polymerase in the degradation of NAD caused by gamma-radiation and N-methyl-N-nitrosourea. Eur. J. Biochem. 101. 135-142 (1979).
15. E. Ben-Hur, H. Utsumi and M. M. Elkind, Inhibitors of poly(ADP-ribose) synthesis enhance X-ray killing of log-phase Chinese hamster cells. Radiat. Res. 97, 546-555 (1984).
16. L. G. Durrant and J. M. Boyle. Potentiation of cell killing by inhibitors of poly(ADP-ribose) polymerase in four rodent cell lines exposed to N-methyi-N-nitrosourea or UV light. Chem. Biol. Interact. 38, 325-338 (1982).
17. N. Nduka, C. J. Skidmore and S. Shall, The enhancement of cytotoxicity of N-methyl-N-nitrosourea and of gamma-radiation by inhibitors of poly(ADP-ribose) polymerase. Eur. J. Biochem. 105, 525-530 (1980).
18. M. R. Horsman, D. J. Chaplin and J. M. Brown. Tumor radiosensitization by nicotinamide: A result of improved perfusion and oxygenation. Radiat. Res. 118, 139-150 (1989).
19. B. Zackrisson, L. Franzén, R. Henriksson, B. Littbrand, M. R. L. Stratford, M. Dennis, A. Rojas and J. Denekamp, Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON). Acta Oncol. 33, 377-381 (1994).
20. A. Rojas, M. C. Joiner and H. Johns, Recovery kinetics in mouse skin and CaNT tumours. Radiother. Oncol. 16, 211-220 (1989).
21. J. Denekamp, Changes in the rate of repopulation during multifraction irradiation of mouse skin. Br. J. Radiol. 46, 381-387 (1973).
22. M. C. Joiner. Extension of the reciprocal dose analysis to the case of multiple fractions plus top-up. Radiother. Oncol. 7, 349-351 (1986).
23. B. G. Douglas and J. F. Fowler. The effect of multiple small doses of X rays on skin reactions in the mouse and a basic interpretation. Radiat. Res. 66, 401-426 (1976).
24. M. C. Joiner and J. Denekamp, The effect of small radiation doses on mouse skin. Br. J. Cancer 53, 63-66 (1986).
25. M. C. Joiner and H. Johns. Renal damage in the mouse: the effect of d(4)-Be neutrons. Radiat. Res. 109, 456-468 (1987).
26. J. J. Broerse. B. J. Mijnheer and J. R. Williams, European protocol for neutron dosimetry for external beam therapy. Br. J. Radiol. 54, 882-898 (1981).
27. E. L. Alpen and F. A. Stewart. Radiation nephritis and anaemia: A functional assay for renal damage after irradiation. Br. J. Radiol. 57, 185-187 (1984).
28. F. A. Stewart, J. A. Soranson, E. L. Alpen, M. V. Williams and J. Denekamp, Radiation-induced renal damage: The effects of hyperfractionation. Radiat. Res. 98, 407-420 (1984).
29. M. V. Williams and J. Denekamp, Radiation induced renal damage in mice. Influence of overall treatment time. Radiother. Oncol. 1, 355-367 (1984).
30. K. U. Eckardt, S. T. Koury, C. C. Tan, S. J. Schuster, B. Kaissling, P. J. Ratcliffe and A. Kurtz, Distribution of erythropoietin producing cells in rat kidneys during hypoxic hypoxia. Kidney Int. 43, 815-823 (1993).
31. H. Johns and M. C. Joiner, A simple method for fitting curves to dose-effect data for functional damage. Int. J. Radiat. Biol. 60, 533-541 (1991).
32. S. L. Tucker, Testing the fit of the LQ model to isoeffect data. Int. J. Radiat. Oncol. Biol. Phys. 12, 291-292 (1986).
33. H. D. Thames, An 'incomplete-repair' model for survival after fractionated and continuous irradiations. Int. J. Radiat. Biol. 47, 319-339 (1985).
34. M. C. Joiner, A. Rojas and H. Johns, Renal damage in the mouse: Repair kinetics at 2 and 7 Gy per fraction. Radiat. Res. 134, 355-363 (1993).
35. A. Rojas, R. J. Hodgkiss, M. R. L. Stratford, M. F. Dennis and H. Johns, Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations. Br. J. Cancer 68, 1115-1121 (1993).
36. M. R. L. Stratford and M. F. Dennis, High-performance liquid Chromatographic determination of nicotinamide and its metabolites in human and murine plasma and urine. J. Chromatogr. 582, 145-151 (1992).
37. A. C. Begg, Additivity versus repair inhibition in fractionated treatments combining drugs and X rays: A theoretical analysis. Int. J. Radiat. Oncol. Biol. Phys. 13, 921-927 (1987).
38. M. R. Horsman, P. V. Hansen and J. Overgaard, Radiosensitization by nicotinamide in tumors and normal tissues: the importance of tissue oxygenation status. Int. J. Radiat. Oncol. Biol. Phys. 16, 1273-1276 (1989).
39. J. H. Hendry and M. L. Sutton, Care with radiosensitizers. Br. J. Radiol. 51, 927-928 (1978).
40. F. A. Stewart, J. Denekamp and V. S. Randhawa, Skin sensitization by misonidazole: a demonstration of uniform mild hypoxia. Br. J. Cancer 45, 869-877 (1982).
41. A. Rojas, B. Vojnovic. H. Johns, M. C. Joiner, C. Martindale, J. F. Fowler and J. Denekamp, Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules. Radiother. Oncol., in press.
42. D J. Chaplin, C. E. Peters, M. R. Horsman and M. J. Trotter. Drug induced perturbations in tumor blood flow: therapeutic potential and possible implications. Radiother. Oncol. 20, 93-101 (1991).
43. J. M. Brown, Evidence for acutely hypoxic cells in mouse tumours and a possible mechanism of reoxygenation. Br. J. Radiol. 52, 650-656 (1979).
44. Y. Hiromatsu. M. Sato. K. Yamada and K. Nonaka, Inhibitory effects of nicotinamide on recombinant human interferon-gamma-induced intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigen expression on cultured human endothelial cells. Immunol. Lett. 31, 35-39 (1992).
45. M. J. Trotter, D. J. Chaplin and P. L. Olive. Possible mechanisms for intermittent blood flow in the murine SCCVII carcinoma. Int. J. Radiat. Biol. 60, 139-146 (1991).
46. I. Lee, Y. Boucher and R. K. Jain, Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications. Cancer Res. 52, 3237-3240 (1992).
47. H. D. Roh. Y. Boucher, S. Kalnicki, R. Buchsbaum, W. D. Bloomer and R. K. Jain, Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response. Cancer Res. 51, 6695-6698 (1991).
48. J. Denekamp and M. C. Joiner, The potential benefit from a perfect radiosensitizer and its dependence on reoxygenation. Br. J. Radiol. 55, 657-663 (1982)
49. R. Hille and R. F. Anderson. Electron transfer in milk xanthine oxidase as studied by pulse radiolysis. J. Biol. Chem. 266, 5608-5615 (1991).